Cargando…

The Use of Regenerative Medicine in the Management of Invasive Bladder Cancer

Muscle invasive and recurrent nonmuscle invasive bladder cancers have been traditionally treated with a radical cystectomy and urinary diversion. The urinary diversion is generally accomplished through the creation of an incontinent ileal conduit, continent catheterizable reservoir, or orthotopic ne...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hyndman, Matthew E., Kaye, Deborah, Field, Nicholas C., Lawson, Keith A., Smith, Norm D., Steinberg, Gary D., Schoenberg, Mark P., Bivalacqua, Trinity J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2012
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3457671/ https://www.ncbi.nlm.nih.gov/pubmed/23019421 http://dx.doi.org/10.1155/2012/653652

Ejemplares similares

Do African American Patients Treated with Radical Cystectomy for Bladder Cancer have Worse Overall Survival? Accounting for Pathologic Staging and Patient Demographics Beyond Race Makes a Difference
por: Kaye, Deborah R., et al.
Publicado: (2016)

Regenerative Medicine for Erectile Dysfunction Following Radical Prostatectomy: Are we Ready?
por: Albersen, Maarten, et al.
Publicado: (2016)

Oncological Outcomes of Sequential Intravesical Gemcitabine and Docetaxel in Patients with Non-Muscle Invasive Bladder Cancer
por: Milbar, Niv, et al.
Publicado: (2017)

The good, bad, and the ugly of regenerative therapies for erectile dysfunction
por: Campbell, Jeffrey D., et al.
Publicado: (2020)

Innumerable Condyloma Acuminatum Tumors of the Bladder
por: Murray, Alexandra J., et al.
Publicado: (2017)

The ratio of CD8 to Treg tumor-infiltrating lymphocytes is associated with response to cisplatin-based neoadjuvant chemotherapy in patients with muscle invasive urothelial carcinoma of the bladder
por: Baras, Alexander S., et al.
Publicado: (2016)

Predictive models of response to neoadjuvant chemotherapy in muscle-invasive bladder cancer using nuclear morphology and tissue architecture
por: Mi, Haoyang, et al.
Publicado: (2021)

Organoid culture of bladder cancer cells
por: Yoshida, Takahiro, et al.
Publicado: (2018)

Identification and Validation of Protein Biomarkers of Response to Neoadjuvant Platinum Chemotherapy in Muscle Invasive Urothelial Carcinoma
por: Baras, Alexander S., et al.
Publicado: (2015)

Regenerative Medicine Strategies for Treating Neurogenic Bladder
por: Yoo, James J., et al.
Publicado: (2011)

Epigenetic inactivation of VGF associated with Urothelial Cell Carcinoma and its potential as a non-invasive biomarker using urine
por: Hayashi, Masamichi, et al.
Publicado: (2014)

Diagnosing and Treating Inflammatory Myofibroblastic Tumor of the Bladder
por: Alam, Ridwan, et al.
Publicado: (2016)

Correction: Identification and Validation of Protein Biomarkers of Response to Neoadjuvant Platinum Chemotherapy in Muscle Invasive Urothelial Carcinoma
por: Baras, Alexander S., et al.
Publicado: (2015)

A Case Report of Primary Recurrent Malignant Melanoma of the Urinary Bladder
por: Truong, Hong, et al.
Publicado: (2013)

Blue light flexible cystoscopy with hexaminolevulinate in non-muscle-invasive bladder cancer: review of the clinical evidence and consensus statement on optimal use in the USA — update 2018
por: Lotan, Yair, et al.
Publicado: (2019)

Adenocarcinoma of the Ileal Conduit in a Patient Born With Classic Bladder Exstrophy
por: Ko, Joan S., et al.
Publicado: (2013)

The Future of Intravesical Drug Delivery for Non-Muscle Invasive Bladder Cancer
por: Douglass, Laura, et al.
Publicado: (2016)

A Phase I/II study of vesigenurtacel-l (hs-410) or placebo in combination with Bacillus Calmette-Guérin (BCG) in patients with non-muscle invasive bladder cancer (NMIBC)
por: Steinberg, Gary D, et al.
Publicado: (2014)

Surgical excision of a large, verrucous, scrotal mass in a patient with HSV-2 and HIV-1 co-infection
por: Luderowski, Eva, et al.
Publicado: (2018)

Regenerative Medicine in the State of Florida: Letter Outlining the Florida Organization for Regenerative Medicine
por: Bruce, Charles J., et al.
Publicado: (2018)

CD24 regulates cancer stem cell (CSC)-like traits and a panel of CSC-related molecules serves as a non-invasive urinary biomarker for the detection of bladder cancer
por: Ooki, Akira, et al.
Publicado: (2018)

Regenerative Medicine: Pharmacological Considerations and Clinical Role in Pain Management
por: Kaye, Alan D., et al.
Publicado: (2022)

Three-dimensional organoid culture reveals involvement of Wnt/β-catenin pathway in proliferation of bladder cancer cells
por: Yoshida, Takahiro, et al.
Publicado: (2018)

An epigenetic marker panel for recurrence risk prediction of low grade papillary urothelial cell carcinoma (LGPUCC) and its potential use for surveillance after transurethral resection using urine
por: Maldonado, Leonel, et al.
Publicado: (2014)

Is a functional urinary bladder attainable through current regenerative medicine strategies?
por: Sharma, Arun K.
Publicado: (2013)

Tissue Engineering and Regenerative Medicine in Pediatric Urology: Urethral and Urinary Bladder Reconstruction
por: Casarin, Martina, et al.
Publicado: (2022)

Urothelial Carcinoma
por: Chow, Nan-Haw, et al.
Publicado: (2012)

Regenerative Medicine
por: Morishita, Ryuichi
Publicado: (2014)

Biomanufacturing in low Earth orbit for regenerative medicine
por: Sharma, Arun, et al.
Publicado: (2021)

Systematic Evaluation of Imaging Features of Early Bladder Cancer Using Computed Tomography Performed before Pathologic Diagnosis
por: Malik, Rubab F., et al.
Publicado: (2023)

Current penile-rehabilitation strategies: Clinical evidence
por: Segal, Robert L., et al.
Publicado: (2013)

Evaluation and treatment of an unusual urachal mass: a case report
por: Cooper, John L, et al.
Publicado: (2015)

Evolving therapies for Peyronie’s disease: how can we work towards new drugs?
por: Milenkovic, Uros, et al.
Publicado: (2020)

Functional imaging for regenerative medicine
por: Leahy, Martin, et al.
Publicado: (2016)

Japan's challenges of translational regenerative medicine: Act on the safety of regenerative medicine
por: Tobita, Morikuni, et al.
Publicado: (2016)

Cytocentric measurement for regenerative medicine
por: Henn, Alicia D., et al.
Publicado: (2023)

Regenerative Medicine for the Cornea
por: Oie, Yoshinori, et al.
Publicado: (2013)

Bioprinting in Regenerative Medicine
por: Monti, Manuela
Publicado: (2016)

Regenerative Medicine in Diabetes
por: Matveyenko, Aleksey, et al.
Publicado: (2015)

Telocytes in regenerative medicine
por: Bei, Yihua, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_fuspmvfnsq31pmvlc4jb7srcel